Galliprant Video Homepage Still

Understand OA, Then Fight It

1 in 5 dogs suffer in silence from canine osteoarthritis (OA)1 – a chronic, progressive disease. Early diagnosis and intervention can help reduce discomfort and disrupt the progressive cycle of multidimensional deterioration.2

  • Stages

    While OA can occur at any stage in a dog’s life, there are factors that can increase risk

  • Symptoms

    Dogs don't always show overt signs of pain, so being alert to subtle behavioral changes is critical

  • Treatment

    Treatment for canine OA requires a multimodal approach

Get to the Bones of OA

Early OA Diagnosis for Better Pain Management

Nothing troubles veterinarians more than seeing a dog in pain. You want to provide the best care but often worry about the long-term effects of medication. However, waiting to treat OA until later in a dog’s life may be less effective.

Dogs can develop sensitization of the central nervous system after OA develops, causing maladaptive pain 3. Once the maladaptive pain sets in, pain management may be less effective.

Galliprant is an effective non-COX-inhibiting NSAID, providing targeted pain relief for canine OA.
4a-pack-20mg-60mg-100-90ct-Gal-712 x 712
  • Specifically targets the EP4 receptor, the primary mediator of canine OA pain and inflammation4

  • Galliprant’s mode of action targets canine OA pain and inflammation while reducing the impact on GI, kidney and liver homeostasis 4, 5

  • No labeled requirement for serum biochemical evaluation makes way for flexibility in appropriate long-term monitoring*

Get GalliprantTalk to Us

*If Galliprant is used long-term, appropriate monitoring is recommended.

Treat Canine OA Pain With Confidence

Find support through our resources to stage, diagnose, and treat OA.

Discover Our Resources
6a-COAST-Tool-Gal-711 x 339

Introducing a New Staging System with COAST

Diagnose, stage and monitor OA with the Canine Osteoarthritis Staging Tool (COAST).

6c-vet-smiling-on-chair-Gal-500 x 290

A Case of Inspiration

Feel inspired by the stories of veterinarians making a meaningful impact in the lives of their patients and their families.

4a-pack-20mg-60mg-100-90ct-Gal-750 x 562.jpg

Treat Canine OA Pain with Confidence

Galliprant is a non-COX-inhibiting NSAID that delivers targeted, effective pain relief from the earliest diagnosed stages of OA.2* Start managing OA pain with Galliprant.

*The safe use of Galliprant has not been evaluated in dogs younger than 9 months of age and less than 8 lbs (3.6 kg)

65 Years of Experience

Serving animals and caregivers since 1954

90 countries worldwide

Products sold in over 90 countries

7a-Elanco-HQ-Gal-750 x 562

At Elanco, we provide those who raise and care for animals with solutions that empower them to advance a vision of food and companionship enriching life.

Get to Know Us

Indication

Galliprant is an NSAID that controls pain and inflammation associated with osteoarthritis in dogs.

Important Safety Information

Not for use in humans. For use in dogs only. Keep this and all medications out of reach of children and pets. Store out of reach of dogs and other pets in a secured location in order to prevent accidental ingestion or overdose. Do not use in dogs that have a hypersensitivity to grapiprant. If Galliprant is used long term, appropriate monitoring is recommended. Concomitant use of Galliprant with other anti-inflammatory drugs, such as COX-inhibiting NSAIDs or corticosteroids, should be avoided. Concurrent use with other anti-inflammatory drugs or protein-bound drugs has not been studied. The safe use of Galliprant has not been evaluated in dogs younger than 9 months of age and less than 8 lbs (3.6 kg), dogs used for breeding, pregnant or lactating dogs, or dogs with cardiac disease. The most common adverse reactions were vomiting, diarrhea, decreased appetite, and lethargy. Click here for full prescribing information.

Contact your Elanco or distributor representative, or call Elanco (1-888-545-5973) to discover how you can incorporate Galliprant into your canine OA protocol today.


Connect with Galliprant

Let’s keep in touch


Elanco, Galliprant and the diagonal bar logo are trademarks of Elanco or its affiliates.

© 2020 Elanco. PM-US-19-1925